Related Experiment Video
Updated: Jun 29, 2025
07:59
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
Published on: March 4, 2017
8.9K
Nano-radiopharmaceuticals as therapeutic agents
Tanu Dixit1, Nayomi Dave1, Kausani Basu1
1Symbiosis School of Biological Sciences, Faculty of Medical and Health Sciences, Symbiosis International (Deemed University), Lavale, Pune, India.
Frontiers in Medicine
|April 1, 2024
Summary
This review explores nano-radiopharmaceuticals for targeted disease treatment. Nanosystems enhance radiopharmaceutical delivery, improving therapeutic efficacy and safety for various disorders.
Area of Science:
- Nuclear Medicine
- Nanotechnology
Background:
- Radiopharmaceuticals are used in nuclear medicine for diagnosis and treatment.
- High radiation doses can cause adverse effects.
- Nanosystems can improve radiopharmaceutical targeting and pharmacokinetics.
Purpose of the Study:
- To review the therapeutic applications of nano-radiopharmaceuticals.
- To discuss targeted cancer therapy using nano-radiopharmaceuticals.
- To explore nanotools for nano-radiopharmaceutical delivery.
Main Methods:
- Review of existing literature on nano-radiopharmaceuticals.
- Analysis of nanosystem applications in nuclear medicine.
- Discussion of targeted delivery strategies.
Main Results:
- Nanosystems enhance the targeting of radiopharmaceuticals.
- Nano-radiopharmaceuticals offer potential for targeted cancer therapy.
- Further research is needed to confirm safety and efficacy.
Conclusions:
- Nano-radiopharmaceuticals represent a promising therapeutic approach.
- Targeted delivery systems are crucial for optimizing nano-radiopharmaceutical therapy.
- Continued investigation into safety and efficacy is essential.
